These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [The best of valvular heart disease in 2006]. de Gevigney G; Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561 [TBL] [Abstract][Full Text] [Related]
7. Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart disease. Boudes A; Lavoute C; Avierinos JF; Le Dolley Y; Villacampa C; Salem A; Loundou AD; Michel N; Renard S; Habib G Eur J Echocardiogr; 2011 Sep; 12(9):688-95. PubMed ID: 21810827 [TBL] [Abstract][Full Text] [Related]
8. Adverse effects of benfluorex on heart valves and pulmonary circulation. Szymanski C; Andréjak M; Peltier M; Maréchaux S; Tribouilloy C Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):679-86. PubMed ID: 24817577 [TBL] [Abstract][Full Text] [Related]
9. Benfluorex-induced severe primary tricuspid and mitral regurgitation requiring a double-valve replacement. Eugène M; Bruneval P; Bonnet N; Attias D Eur J Cardiothorac Surg; 2018 Jul; 54(1):195. PubMed ID: 29444226 [No Abstract] [Full Text] [Related]
10. Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus. Weill A; Païta M; Tuppin P; Fagot JP; Neumann A; Simon D; Ricordeau P; Montastruc JL; Allemand H Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1256-62. PubMed ID: 20945504 [TBL] [Abstract][Full Text] [Related]
12. Frequency of drug-induced valvular heart disease in patients previously exposd to benfluorex: a multicentre prospective study. Tribouilloy C; Maréchaux S; Jobic Y; Jeu A; Ederhy S; Donal E; Réant P; Arnalsteen E; Boulanger J; Garban T; Ennezat PV; Andréjak M; Rusinaru D Eur Heart J; 2013 Dec; 34(46):3580-7. PubMed ID: 24014218 [TBL] [Abstract][Full Text] [Related]
13. Food and Drug Administration criteria for the diagnosis of drug-induced valvular heart disease in patients previously exposed to benfluorex: a prospective multicentre study. Maréchaux S; Rusinaru D; Jobic Y; Ederhy S; Donal E; Réant P; Arnalsteen E; Boulanger J; Garban T; Ennezat PV; Jeu A; Szymanski C; Tribouilloy C Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):158-65. PubMed ID: 25368209 [TBL] [Abstract][Full Text] [Related]
14. Mitral and aortic valvular disease associated with benfluorex use. Etienne Y; Jobic Y; Frachon I; Fatemi M; Castellant P; Quintin-Roué I J Heart Valve Dis; 2011 May; 20(3):348-50. PubMed ID: 21714428 [TBL] [Abstract][Full Text] [Related]
15. Increased risk of left heart valve regurgitation associated with benfluorex use in patients with diabetes mellitus: a multicenter study. Tribouilloy C; Rusinaru D; Maréchaux S; Jeu A; Ederhy S; Donal E; Réant P; Arnalsteen E; Boulanger J; Ennezat PV; Garban T; Jobic Y Circulation; 2012 Dec; 126(24):2852-8. PubMed ID: 23143159 [TBL] [Abstract][Full Text] [Related]
16. [About the settlement of litigations concerning the harm caused by benfluorex (Mediator®)]. Nicot P; Frachon I; Hill C Presse Med; 2013 Apr; 42(4 Pt 1):411-8. PubMed ID: 23490638 [TBL] [Abstract][Full Text] [Related]
17. Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France. Fournier A; Zureik M Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):343-51. PubMed ID: 22318872 [TBL] [Abstract][Full Text] [Related]
19. Cardiac valvular surgery and history of anorectic drug intake: A retrospective study of a large population of benfluorex-exposed patients. Laurent M; Ennezat PV; Malergue MC; Bruneval P; Arch Cardiovasc Dis; 2022; 115(6-7):348-358. PubMed ID: 35697655 [TBL] [Abstract][Full Text] [Related]
20. Successful surgical repair of mitral and tricuspid valves regurgitation associated with Behçet's disease. Ozbek C; Yetkin U; Postacı N; Güneş T; Yürekli I; Gürbüz A Anadolu Kardiyol Derg; 2010 Oct; 10(5):E23-4. PubMed ID: 20929691 [No Abstract] [Full Text] [Related] [Next] [New Search]